Aia nā hōʻike hou e hōʻemi nui ana ka antibody COVID-19 no ka maʻi ma mua i ka hopena o ka maʻi hou i ka wā e hiki mai ana.
Ua ʻike ʻia kahi noiʻi i paʻi ʻia i ka Pōʻakolu ma ka puke moʻolelo JAMA Internal Medicine ua hōʻemi ka poʻe i hoʻāʻo maikaʻi no COVID-19 i ka maʻi coronavirus ma mua o ka poʻe i hoʻāʻo maikaʻi ʻole no nā antibodies.
Ua ʻōlelo ʻo Kauka Douglas Lowy: “Ua hoʻemi ʻia nā hopena o kēia noiʻi ʻana ma kahi helu o 10, akā loaʻa iaʻu kekahi mau hōʻailona e pili ana i kēia.ʻO ia hoʻi, he manaʻo nui paha kēia o ka hōʻemi.He ʻoiaʻiʻo paha kēia.ʻO ka manaʻo haʻahaʻa o ka hōʻemi. "ʻO ia ka mea kākau o ka noiʻi a me ke poʻokela poʻokela o ka National Cancer Institute.
Ua ʻōlelo ʻo ia: "Noʻu, ʻo ka memo nui loa-e hoʻemi ʻia.""ʻO ka lawe nui ʻana ʻo ia nā antibodies maikaʻi ma hope o nā maʻi kūlohelohe e pili ana i ka pale ʻana i nā maʻi hou."
Ua hoʻohui ʻo Lowy, ʻo ka poʻe i hoʻōla mai COVID-19 pono e hoʻopaʻa ʻia i ko lākou manawa.
Ua noiʻi nā mea noiʻi mai ka National Cancer Institute a me nā ʻoihana e like me LabCorp, Quest Diagnostics, Aetion Inc. a me HealthVerity i ka ʻikepili o ka ʻoi aku o 3.2 miliona mau kānaka ma United States i hoʻopau i ka hoʻāʻo antibody COVID-19 ma waena o Ianuali a me ʻAukake i ka makahiki i hala.I kēia mau hoʻokolohua, ua maikaʻi ka 11.6% o nā antibodies COVID-19 a ʻo 88.3% ka maikaʻi ʻole.
I ka ʻikepili hahai, ua ʻike nā mea noiʻi ma hope o 90 mau lā, ʻo 0.3% wale nō o ka poʻe i hoʻāʻo maikaʻi i nā antibodies COVID-19 i hoʻāʻo maikaʻi ʻia no ka maʻi coronavirus.Ma waena o nā mea maʻi me nā hopena hoʻāʻo antibody COVID-19 maikaʻi ʻole, 3% i ʻike ʻia me ka maʻi coronavirus i ka manawa like.
Ma ke ʻano holoʻokoʻa, ʻike ʻia kēia haʻawina, a hōʻike ia i kahi hui ma waena o kahi hopena hoʻāʻo antibody COVID-19 maikaʻi a me ka hōʻemi ʻana o ka maʻi ma hope o 90 mau lā-akā, pono hou ka noiʻi e hoʻoholo ai i ke kumu a me ka lōʻihi o ka pale ʻana o ka antibody.
Ua ʻōlelo ʻo Roy, pono ka noiʻi hou e hoʻoholo i ka hopena o ka reinfection i hoʻokumu ʻia e kekahi o nā ʻano ʻano coronavirus e kū mai ana.
Ua ʻōlelo ʻo Lowe: “I kēia manawa aia kēia mau hopohopo.He aha kā lākou manaʻo?ʻO ka pane pōkole loa ʻaʻole mākou ʻike.Ua hoʻoikaika ʻo ia i ka poʻe e hoʻāʻo i ka maikaʻi no nā antibodies e hoʻopaʻa mau ʻia i ka COVID-19.
Ua ʻike ʻia ʻo ka hapa nui o nā mea maʻi e hoʻōla ana mai COVID-19 he antibodies, a i kēia manawa, ʻike ʻia ka reinfection - akā "pehea ka lōʻihi o ka pale ʻana o ka antibody ma muli o nā maʻi kūlohelohe" ʻaʻole maopopo," ʻo Dr. Mitchell Katz o NYC Health + Ua kākau ka ʻōnaehana mālama ola o ka haukapila ma kahi hoʻoponopono i paʻi ʻia me ka noiʻi hou ma JAMA Internal Medicine.
Ua kākau ʻo Katz: "No laila, ʻoiai ke ʻano o ke kūlana antibody, ua ʻōlelo ʻia e kiʻi i ka kano SARS-CoV-2."ʻO SARS-CoV-2 ka inoa o ka maʻi coronavirus e hoʻokumu ai i ka COVID-19.
Ua kākau ʻo ia: "ʻAʻole ʻike ʻia ka lōʻihi o ka pale antibody i hāʻawi ʻia e nā kano.""Pono e ʻike i ka lōʻihi o ka pale ʻana o nā antibodies ma muli o ka maʻi kūlohelohe a i ʻole ka lāʻau lapaʻau.ʻO ka manawa wale nō e haʻi mai.
Ke komo nei ʻo Hearst Television i nā papahana kālepa pili, ʻo ia hoʻi, e loaʻa iā mākou nā komisina uku no nā kūʻai ʻana ma o nā loulou i nā pūnaewele kūʻai aku.
Ka manawa hoʻouna: Feb-25-2021